CytoSorbents (OTC:CTSO) announced today that the U.S. Army has awarded it a $1.1 million contract to develop its HemoDefend-BGA adsorber. HemoDefend-BGA can rapidly remove more than 99% of anti-A and anti-B antibodies from plasma to create a “universal plasma” that could be administered to anyone, irrespective of blood type, while maintaining critical coagulation activity, according to […]
U.S. Department of Defense
Federal watchdog tells HHS, FEMA and DoD: You can do better on COVID-19
The General Accounting Office (GAO) took three major federal departments to task today on their coronavirus responses and gave some pointed advice for the future. In a wide-ranging report, the GAO told the Department of Health and Human Services (HHS), the Federal Emergency Management Agency (FEMA) and the Department of Defense (DoD) how to better manage coronavirus-related […]
Report: Why is there still an N95 shortage?
The nationwide shortage of N95 respirators needed by healthcare workers and others during the coronavirus pandemic shows no indications of letting up, according to an article in today’s Washington Post. The newspaper cites a lack of inter-industry cooperation on N95 production, the Trump administration’s use of the Defense Production Act to force companies to make […]
Feds unveil COVID-19 vaccine distribution plan
The Trump administration today released a plan to distribute an eventual COVID-19 vaccine free of charge, initially to targeted groups and more broadly as supply increases. The government is planning a phased distribution using a contract awarded to McKesson in August. The first recipients could include: Healthcare personnel likely to be exposed to or treat […]
Feds ink COVID-19 vaccine distro deal with McKesson
The U.S. Dept. of Health and Human Services (HHS) and Defense Dept. (DoD) announced a COVID-19 vaccine distribution deal with McKesson. Under Operation Warp Speed, McKesson will become a central distributor of future COVID-19 vaccines and related supplies needed to administer the pandemic vaccinations, according to a news release. Get the full story at our sister […]
DoD paying Biomérieux subsidiary $3.1M to boost COVID-19 test production
The U.S. government announced that it signed a $3.1 million agreement with Biomérieux subsidiary BioFire to expand production of its COVID-19 test. Government funding came from the U.S. Defense Dept. (DoD), in coordination with the Dept. of Health and Human Services (HHS), according to a news release. BioFire’s COVID-19 test received FDA emergency use authorization […]
U.S. to spend $1B for doses of J&J’s COVID-19 vaccine candidate
The U.S. Dept. of Health and Human Services and Defense Dept. agreed to a $1 billion deal for a vaccine candidate from Johnson & Johnson (NYSE:JNJ). HHS and DoD announced the agreement with Janssen Pharmaceutical, as the J&J subsidiary is set to offer large-scale manufacturing and the delivery of its COVID-19 vaccine candidate, with the federal […]
HHS, DOD invest $7.6m in Hologic COVID-19 test samples
The U.S. Dept. of Health and Human Services (HHS) and Defense Dept. (DoD) announced a $7.6 million contract for COVID-19 testing from Hologic (NSDQ:HOLX). Marlborough, Mass.-based Hologic will receive the contract with a ceiling of $7.6 million so it can expand production of custom sample collection and processing consumables for COVID-19 testing, according to a news […]
Inovio to scale up production of smart delivery device for potential COVID-19 vaccine
Inovio Pharmaceuticals (NSDQ:INO) announced that it received $71 million from the U.S. Defense Dept. to support its Cellectra 3PSP smart device. Funding from the DoD is set to support large-scale manufacturing for the Cellectra 3PSP and the procurement of Cellectra 2000 devices, which are used to deliver its INO-4800 COVID-19 vaccine candidate directly into the skin. […]
HHS taps Pfizer to produce millions of COVID-19 vaccine doses
Two U.S. government agencies today announced an agreement with Pfizer (NYSE:PFE) for production and delivery of 100 million doses of a COVID-19 vaccine. The U.S. Dept. of Health and Human Services, along with the U.S. Defense Dept., agreed to the large-scale production and U.S. delivery deal once Pfizer’s vaccine is successfully manufactured and approved. In addition to […]
U.S. paying Novavax $1.6b to ramp up COVID-19 vaccine manufacturing
The U.S. Health and Human Services Dept. and Defense Dept. announced a joint agreement with Novavax (NSDQ:NVAX) worth $1.6 billion to scale the manufacturing of its COVID-19 vaccine candidate. Gaithersburg, Md.-based Novavax’s commercial-scale manufacturing is expected to produce 100 million doses of the investigational vaccine that would become available for use in clinical trials or, should the […]
